<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04974580</url>
  </required_header>
  <id_info>
    <org_study_id>GR120236</org_study_id>
    <nct_id>NCT04974580</nct_id>
  </id_info>
  <brief_title>Research and Innovation to Stop E-cigarette/Vaping in Young Adults</brief_title>
  <acronym>(RISE)</acronym>
  <official_title>Young Adult Vaping Cessation: A Randomized Trial Examining Phone Coaching, Text-based Digital Intervention, and Nicotine Replacement Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Optum, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to test intervention components to help young adults quit vaping. A&#xD;
      2x2 factorial design will be used where all participants receive quitline-delivered&#xD;
      behavioral phone counseling, and components to be tested are a digital intervention (with&#xD;
      text and online cessation support) and nicotine replacement therapy (NRT).&#xD;
&#xD;
      The research questions and hypotheses for this study are:&#xD;
&#xD;
        1. Which components and combinations of intervention yield the greatest success rates for&#xD;
           exclusive vaping cessation among young adult exclusive e-cigarette users? H1: The&#xD;
           complete condition (NRT + digital) will yield significantly higher rates of cessation&#xD;
           compared to the control condition (quitline only).&#xD;
&#xD;
        2. Does 8 weeks of nicotine replacement therapy (NRT) improve initial cessation outcomes&#xD;
           relative to no NRT.&#xD;
&#xD;
           H2: Providing NRT will yield significantly higher quit rates compared to the No NRT&#xD;
           condition.&#xD;
&#xD;
        3. Do tailored text-messages and online support during cessation improve initial cessation&#xD;
           outcomes relative to no digital content? Are young adult vapers engaged with and&#xD;
           satisfied with digital cessation tools? H3: Digital support will yield significantly&#xD;
           higher quit rates compared to no digital support.&#xD;
&#xD;
      H4: Higher engagement in digital content will be associated with higher cessation success&#xD;
      rates.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will recruit a national, nonprobability sample of young adults (18-24 year&#xD;
      olds) who vape nicotine. All study components will be delivered by phone, mail, online, and&#xD;
      mobile device. All participants will receive up to 2 coaching calls and will be randomized to&#xD;
      one of four groups: no NRT, no Digital; Digital, no NRT; NRT, no Digital; or NRT and Digital.&#xD;
&#xD;
      Participants (final sample size n = 504) must complete one coaching call to be enrolled in&#xD;
      the study. The two coaching calls (approximately 10-20 minutes each) focus on 5 &quot;keys&quot; for&#xD;
      quitting: setting a quit date, conquering urges, managing physical withdrawal symptoms (or&#xD;
      addressing nicotine replacement needs for the NRT groups), vape-proofing environment, and&#xD;
      social supports.&#xD;
&#xD;
      In this real-world trial, coaches will be trained to assess vaping use and dose NRT taking&#xD;
      into account use frequency, nicotine level, and participant preference, leveraging quitline&#xD;
      standard protocols. Participants may be sent up to 8 weeks (patch, gum, and or lozenge) of&#xD;
      product in two shipments. Combination NRT (patch plus gum or lozenge) may be offered.&#xD;
&#xD;
      The digital cessation content includes a text messaging program with links to online&#xD;
      education and support materials. The text program will be tailored to a participant's quit&#xD;
      stage, and include education, tips, motivational messages, and assessment questions yielding&#xD;
      tailored content. The online content (brief videos, audio podcasts, quizzes, etc) can be&#xD;
      viewed in small segments via texted links. Participants can also engage with the online&#xD;
      content by navigating through lessons or suggested content.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>A 2x2 factorial design will be used where all participants receive quitline-delivered phone counseling, and components to be tested are a digital intervention (with text-based cessation and online cessation support) and nicotine replacement therapy (NRT).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Evaluators are blinded to the study arm assignment of participants.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>7-day point prevalence vaping abstinence</measure>
    <time_frame>3 months after Call 1</time_frame>
    <description>Self-report of no use of e-cigarettes in the past 7 days at the time of the 3-month outcome survey.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vaping abstinence</measure>
    <time_frame>Assessed 3 months after study enrollment</time_frame>
    <description>Self-reported 30-day point prevalence vaping abstinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E-cigarette dependence - PROMIS-E</measure>
    <time_frame>Assessed 3 months after study enrollment</time_frame>
    <description>Self-reported e-cigarette dependence using the Patient Reported Outcomes Measurement Information System - E-cigarettes (PROMIS-E) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E-cigarette dependence - Penn State E-cigarette Dependence Questionnaire</measure>
    <time_frame>Assessed 3 months after study enrollment</time_frame>
    <description>Self-reported e-cigarette dependence using the Penn State E-cigarette Dependence questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in e-cigarette use frequency</measure>
    <time_frame>Assessed 3 months after study enrollment</time_frame>
    <description>Self-reported e-cigarette use frequency (changes in number of days vaped in the last 30 days)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">840</enrollment>
  <condition>Nicotine Dependence</condition>
  <condition>E-Cig Use</condition>
  <arm_group>
    <arm_group_label>CoachingOnlyArm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phone Coaching; no Digital Coaching, no NRT: This arm will receive only the two phone counseling calls which all other arms will receive.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DigitalArm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phone Coaching + Digital Coaching; no NRT: This arm will receive digital content (text messages with links to online materials) in addition to to the two phone counseling calls which all arms will receive.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CoachingNRTArm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phone Coaching + NRT; no Digital Coaching: This arm will receive Nicotine Replacement Therapy (NRT) in addition to the two phone counseling calls which all arms will receive.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DigitalNRTArm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will receive digital content (text messages with links to online materials) AND Nicotine Replacement Therapy (NRT) in addition to the two phone counseling calls which all arms will receive.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine patch</intervention_name>
    <description>NRT will be discussed and dosed by the study quit coach during coaching calls per quitline dosing protocols. NRT treatment will consist of up to an 8 week supply of nicotine patch, gum, and/or lozenge. NRT will be sent in two 4 week shipments. Participants may be dosed for a single form of NRT or combination NRT (patch plus gum or lozenge) based on coach assessment of nicotine use and participant preference.</description>
    <arm_group_label>CoachingNRTArm</arm_group_label>
    <arm_group_label>DigitalNRTArm</arm_group_label>
    <other_name>Nicotine lozenge</other_name>
    <other_name>Nicotine gum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Phone Counseling</intervention_name>
    <description>Participants in all four arms of the study will receive two proactive phone-based behavioral coaching calls for quitting vaping, which will include making a quit plan, learning to cope with urges to vape, and education on strategies for quitting and staying quit. Calls utilize the quitline evidence-based protocol. The first call lasts approximately 20 minutes, the second calls lasts approximately 10 minutes, and participants are encouraged to call in for ad hoc calls if they would like additional support.</description>
    <arm_group_label>CoachingNRTArm</arm_group_label>
    <arm_group_label>CoachingOnlyArm</arm_group_label>
    <arm_group_label>DigitalArm</arm_group_label>
    <arm_group_label>DigitalNRTArm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Digital Coaching</intervention_name>
    <description>Intervention descriptionText-based vaping cessation program that utilizes evidence-based content from the quitline tobacco cessation protocol, as well as links directing participants to additional online educational content (brief videos, audio content, quizzes, and educational activities).</description>
    <arm_group_label>DigitalArm</arm_group_label>
    <arm_group_label>DigitalNRTArm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Current, regular user of nicotine e-cigarettes (20+ days in the last month)&#xD;
&#xD;
          -  Exclusive e-cigarette user (no other tobacco in the last 30 days; or no other tobacco&#xD;
             in the last 90 days if smoked 100+ cigarettes or cigarillos in lifetime)&#xD;
&#xD;
          -  Interest in quitting in the next 30 days&#xD;
&#xD;
          -  Ownership of a smartphone device&#xD;
&#xD;
          -  Ability to speak and read English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breastfeeding&#xD;
&#xD;
          -  Individuals with schizophrenia or bipolar disorder who do not report that their&#xD;
             condition is currently effectively managed&#xD;
&#xD;
          -  Individuals who have experienced a heart attack or stroke in the two weeks prior, or&#xD;
             who have been diagnosed with rapid/irregular heartbeat or angina in the six months&#xD;
             prior to taking the eligibility screener&#xD;
&#xD;
          -  Other household members in study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liz Klein, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth Hustead</last_name>
    <phone>614-688-0345</phone>
    <email>hustead.7@osu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Hustead, MS</last_name>
      <phone>614-688-0345</phone>
      <email>hustead.7@osu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth Klein, PhD</last_name>
      <phone>6142925424</phone>
      <email>klein.232@osu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Elizabeth Klein, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gentzke AS, Creamer M, Cullen KA, Ambrose BK, Willis G, Jamal A, King BA. Vital Signs: Tobacco Product Use Among Middle and High School Students - United States, 2011-2018. MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164. doi: 10.15585/mmwr.mm6806e1.</citation>
    <PMID>30763302</PMID>
  </reference>
  <reference>
    <citation>Leavens ELS, Stevens EM, Brett EI, Leffingwell TR, Wagener TL. JUUL in school: JUUL electronic cigarette use patterns, reasons for use, and social normative perceptions among college student ever users. Addict Behav. 2019 Dec;99:106047. doi: 10.1016/j.addbeh.2019.106047. Epub 2019 Jul 9.</citation>
    <PMID>31442788</PMID>
  </reference>
  <reference>
    <citation>Graham AL, Jacobs MA, Amato MS. Engagement and 3-Month Outcomes From a Digital E-Cigarette Cessation Program in a Cohort of 27 000 Teens and Young Adults. Nicotine Tob Res. 2020 Apr 21;22(5):859-860. doi: 10.1093/ntr/ntz097.</citation>
    <PMID>31197320</PMID>
  </reference>
  <reference>
    <citation>Brunnemann KD, Hoffmann D. The pH of tobacco smoke. Food Cosmet Toxicol. 1974 Feb;12(1):115-24.</citation>
    <PMID>4459223</PMID>
  </reference>
  <reference>
    <citation>Buchanan ND, Grimmer JA, Tanwar V, Schwieterman N, Mohler PJ, Wold LE. Cardiovascular risk of electronic cigarettes: a review of preclinical and clinical studies. Cardiovasc Res. 2020 Jan 1;116(1):40-50. doi: 10.1093/cvr/cvz256. Review.</citation>
    <PMID>31696222</PMID>
  </reference>
  <reference>
    <citation>Tanwar V, Adelstein JM, Grimmer JA, Youtz DJ, Katapadi A, Sugar BP, Falvo MJ, Baer LA, Stanford KI, Wold LE. Preconception Exposure to Fine Particulate Matter Leads to Cardiac Dysfunction in Adult Male Offspring. J Am Heart Assoc. 2018 Dec 18;7(24):e010797. doi: 10.1161/JAHA.118.010797. Erratum in: J Am Heart Assoc. 2019 Apr 16;8(8):e002293.</citation>
    <PMID>30561255</PMID>
  </reference>
  <reference>
    <citation>Tackett AP, Keller-Hamilton B, Smith CE, Hébert ET, Metcalf JP, Queimado L, Stevens EM, Wallace SW, McQuaid EL, Wagener TL. Evaluation of Respiratory Symptoms Among Youth e-Cigarette Users. JAMA Netw Open. 2020 Oct 1;3(10):e2020671. doi: 10.1001/jamanetworkopen.2020.20671.</citation>
    <PMID>33048131</PMID>
  </reference>
  <reference>
    <citation>Rogers JM. Tobacco and pregnancy: overview of exposures and effects. Birth Defects Res C Embryo Today. 2008 Mar;84(1):1-15. doi: 10.1002/bdrc.20119. Review.</citation>
    <PMID>18383133</PMID>
  </reference>
  <reference>
    <citation>Morean ME, Krishnan-Sarin S, S O'Malley S. Assessing nicotine dependence in adolescent E-cigarette users: The 4-item Patient-Reported Outcomes Measurement Information System (PROMIS) Nicotine Dependence Item Bank for electronic cigarettes. Drug Alcohol Depend. 2018 Jul 1;188:60-63. doi: 10.1016/j.drugalcdep.2018.03.029. Epub 2018 Apr 26. Erratum in: Drug Alcohol Depend. 2020 Jan 1;206:107602.</citation>
    <PMID>29753155</PMID>
  </reference>
  <reference>
    <citation>Foulds J, Veldheer S, Yingst J, Hrabovsky S, Wilson SJ, Nichols TT, Eissenberg T. Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nicotine Tob Res. 2015 Feb;17(2):186-92. doi: 10.1093/ntr/ntu204. Epub 2014 Oct 19.</citation>
    <PMID>25332459</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 2, 2021</study_first_submitted>
  <study_first_submitted_qc>July 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Elizabeth G Klein</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 28, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/80/NCT04974580/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 28, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/80/NCT04974580/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 14, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/80/NCT04974580/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

